Van Laethem, J.-L., Hammel, P., Mornex, F., Azria, D., Van Tienhoven, G., Vergauwe, P., Peeters, M., Polus, M., Praet, M., Mauer, M., Collette, L., Budach, V., Lutz, M., Van Cutsem, E., & Haustermans, K. (2010). Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
Journal of Clinical Oncology, 28 (29), 4450-6. doi:10.1200/JCO.2010.30.3446
https://hdl.handle.net/2268/85358